GSO Capital Partners LP disclosed a new stake in Alnylam Pharmaceuticals, Inc. in a filing on June 30, 2020

Aug 20, 2020
Institutional Holdings Changes
Background Information
GSO evaluates potential opportunities and investments by using the investment process which includes a variety of proprietary and non-proprietary research models and methods of analyses and a variety of both internal and external resources, such as financial newspapers and magazines, research, and reports provided by third parties and corporate rating services. The firm seeks to capitalize on both long- and short-term inefficiencies in the market by investing across a spectrum of products, often employing a bottom-up analysis, utilizing market technical and fundamental analyses to select investments.